[1] GLATZ J F C,LUIKEN J J F P. Dynamic role of the transmembrane glycoprotein CD36 (SR-B2) in cellular fatty acid uptake and utilization[J]. J Lipid Res,2018,59(7):1084-1093. [2] PEPINO M Y,KUDA O,SAMOVSKI D,et al.Structure-function of CD36 and importance of fatty acid signal transduction in fat metabolism[J]. Annu Rev Nutr,2014,34:281-303. [3] SILVERSTEIN R L,FEBBRAIO M. CD36,a scavenger receptor involved in immunity,metabolism,angiogenesis,and behavior[J]. Sci Signal,2009,2(72):re3. [4] LOVE-GREGORY L,SHERVA R,SCHAPPE T,et al.Common CD36 SNPs reduce protein expression and may contribute to a protective atherogenic profile[J]. Hum Mol Genet,2011,20(1):193-201. [5] NICULITE C M,ENCIU A M,HINESCU M E.CD 36:focus on epigenetic and post-transcriptional regulation[J]. Front Genet,2019,10:680. [6] WU G, ZHOU Y, LI L, et al.Platelet Immunology in China: Research and Clinical Applications[J]. Transfus Med Rev. 2017, 31(2):118-125. [7] YAMAMOTO N,AKAMATSU N,SAKURABA H,et al.Platelet glycoprotein IV (CD36) deficiency is associated with the absence (type Ⅰ) or the presence (type Ⅱ) of glycoprotein IV on monocytes[J]. Blood,1994,83(2):392-397. [8] FERNÁNDEZ-RUIZ E,ARMESILLA A L,SÁNCHEZ-MADRID F,et al. Gene encoding the collagen type I and thrombospondin receptor CD36 is located on chromosome 7q11.2[J]. Genomics,1993,17(3):759-761. [9] XU X Z,YE X,XIA W J,et al.Studies on CD36 deficiency in South China:Two cases demonstrating the clinical impact of anti-CD36 antibodies[J]. Thromb Haemost,2013,110(6):1199-1206. [10] WANG J C,LI Y S.CD36 tango in cancer:signaling pathways and functions[J]. Theranostics,2019,9(17):4893-4908. [11] PASCUAL G,AVGUSTINOVA A,MEJETTA S,et al.Targeting metastasis-initiating cells through the fatty acid receptor CD36[J]. Nature,2017,541(7635):41-45. [12] ZHANG Y,ZANG J,WANG B,et al.CD36 genotype associated with ischemic stroke in Chinese Han[J]. Int J Clin Exp Med,2015,8(9):16149-16157. [13] LEE K,GODEAU B,FROMONT P,et al.CD36 deficiency is frequent and can cause platelet immunization in Africans[J]. Transfusion,1999,39(8):873-879. [14] 蔡碧红,王嘉励,叶欣,等. 广州地区无偿献血者CD36缺失频率及血小板输注治疗[J]. 实用医学杂志,2020,36(12):1634-1637. [15] 于晓丽,焦立新. 长春地区无偿献血人群CD36表型筛查[J]. 世界最新医学信息文摘,2019,19(68):31. [16] 赵娜娜,王超,金惠新,等. 合肥地区无偿献血人群CD36抗原缺失的调查[J]. 临床输血与检验,2021,23(2):152-155. [17] 李丽兰,何保仁,周燕,等. CD36基因新突变T538C(Trp180Arg)导致的CD36缺失和序列特异性引物PCR的基因分型技术的建立[J]. 中华医学遗传学杂志,2016,33(5):619-624. [18] YANAI H,CHIBA H,FUJIWARA H,et al.Phenotype-genotype correlation in CD36 deficiency types Ⅰ and Ⅱ[J]. Thromb Haemost,2000,84(3):436-441. [19] IMAI M,TANAKA T,KINTAKA T,et al.Genomic heterogeneity of type Ⅱ CD36 deficiency[J]. Clin Chim Acta,2002,321(1/2):97-106. [20] XU X G,LIU Y,HONG X Z,et al.Variants of CD36 gene and their association with CD36 protein expression in platelets[J]. Blood Transfus,2014,12(4):557-564. [21] LI R S,QIAO Z L,LING B,et al.Incidence and molecular basis of CD36 deficiency in Shanghai population[J]. Transfusion,2015,55(3):666-673. [22] CURTIS B R,ASTER R H.Incidence of the Nak(a)-negative platelet phenotype in African Americans is similar to that of Asians[J]. Transfusion,1996,36(4):331-334. [23] MASUDA Y,TAMURA S,MATSUNO K,et al.Diverse CD36 expression among Japanese population:defective CD36 mutations cause platelet and monocyte CD36 reductions in not only deficient but also normal phenotype subjects[J]. Thromb Res,2015,135(5):951-957. [24] GLATZ J F C,NABBEN M,HEATHER L C,et al. Regulation of the subcellular trafficking of CD36,a major determinant of cardiac fatty acid utilization[J]. Biochim Biophys Acta,2016,1861(10):1461-1471. |